10.19 USD
-0.01 (-0.1%)
10.17 USD
-0.02 (-0.2%)
Taking everything into account, THRN scores 4 out of 10 in our fundamental rating. THRN was compared to 36 industry peers in the Personal Care Products industry. THRN has only an average score on both its financial health and profitability. THRN is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
THRN had positive earnings in the past year.
THRN had a positive operating cash flow in the past year.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.20%, THRN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
THRN has a Return On Equity of 13.21%. This is in the better half of the industry: THRN outperforms 75.00% of its industry peers.
The Return On Invested Capital of THRN (4.69%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for THRN is significantly below the industry average of 11.83%.
The last Return On Invested Capital (4.69%) for THRN is above the 3 year average (2.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROIC | 4.69% |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
1.3 Margins
THRN has a better Profit Margin (7.94%) than 70.00% of its industry peers.
THRN has a Operating Margin of 5.26%. This is comparable to the rest of the industry: THRN outperforms 55.00% of its industry peers.
THRN's Gross Margin of 50.15% is in line compared to the rest of the industry. THRN outperforms 47.50% of its industry peers.
In the last couple of years the Gross Margin of THRN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so THRN is destroying value.
Compared to 1 year ago, THRN has more shares outstanding
Compared to 1 year ago, THRN has a worse debt to assets ratio.
2.2 Solvency
THRN has an Altman-Z score of 3.41. This indicates that THRN is financially healthy and has little risk of bankruptcy at the moment.
THRN has a better Altman-Z score (3.41) than 67.50% of its industry peers.
THRN has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.17, THRN perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.41 |
ROIC/WACC0.5
WACC9.44%
2.3 Liquidity
A Current Ratio of 2.41 indicates that THRN has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.41, THRN is doing good in the industry, outperforming 70.00% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that THRN should not have too much problems paying its short term obligations.
THRN has a Quick ratio (1.13) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
THRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 660.00%, which is quite impressive.
Looking at the last year, THRN shows a very strong growth in Revenue. The Revenue has grown by 23.25%.
The Revenue has been growing by 30.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
3.2 Future
Based on estimates for the next years, THRN will show a very strong growth in Earnings Per Share. The EPS will grow by 55.06% on average per year.
The Revenue is expected to grow by 21.84% on average over the next years. This is a very strong growth
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.82, the valuation of THRN can be described as expensive.
65.00% of the companies in the same industry are more expensive than THRN, based on the Price/Earnings ratio.
THRN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.25.
A Price/Forward Earnings ratio of 16.38 indicates a correct valuation of THRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of THRN indicates a somewhat cheap valuation: THRN is cheaper than 77.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.98, THRN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 |
4.2 Price Multiples
THRN's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates THRN does not grow enough to justify the current Price/Earnings ratio.
THRN's earnings are expected to grow with 55.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y46.48%
EPS Next 3Y55.06%
5. Dividend
5.1 Amount
No dividends for THRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.19
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.03%
Inst Owner Change0%
Ins Owners10.68%
Ins Owner Change0%
Market Cap550.67M
Revenue(TTM)255.95M
Net Income(TTM)20.33M
Analysts80
Price Target8.61 (-15.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-40.77%
Min EPS beat(2)-112.25%
Max EPS beat(2)30.72%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-112.25%
Max EPS beat(4)30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.13%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-9.72%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | 25.59 | ||
| P/B | 3.58 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.38
EY3.73%
EPS(NY)0.62
Fwd EY6.11%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.4
OCFY3.91%
SpS4.74
BVpS2.85
TBVpS2.2
PEG (NY)1.87
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROCE | 5.95% | ||
| ROIC | 4.69% | ||
| ROICexc | 5.07% | ||
| ROICexgc | 6.08% | ||
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% | ||
| FCFM | N/A |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)4.22%
ROICexc(5y)N/A
ROICexgc(3y)5.36%
ROICexgc(5y)N/A
ROCE(3y)3.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 590.87% | ||
| Cap/Sales | 14.33% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.41 |
F-Score5
WACC9.44%
ROIC/WACC0.5
Cap/Depr(3y)158.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
EBIT growth 1Y1143.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.89%
EBIT Next 3Y103.9%
EBIT Next 5YN/A
FCF growth 1Y-266.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.29%
OCF growth 3YN/A
OCF growth 5YN/A
THORNE HEALTHTECH INC / THRN FAQ
What is the ChartMill fundamental rating of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a fundamental rating of 4 / 10 to THRN.
What is the valuation status for THRN stock?
ChartMill assigns a valuation rating of 3 / 10 to THORNE HEALTHTECH INC (THRN). This can be considered as Overvalued.
Can you provide the profitability details for THORNE HEALTHTECH INC?
THORNE HEALTHTECH INC (THRN) has a profitability rating of 4 / 10.
What is the financial health of THORNE HEALTHTECH INC (THRN) stock?
The financial health rating of THORNE HEALTHTECH INC (THRN) is 4 / 10.
Is the dividend of THORNE HEALTHTECH INC sustainable?
The dividend rating of THORNE HEALTHTECH INC (THRN) is 0 / 10 and the dividend payout ratio is 0%.